Title: Impact of magnetic resonance on breast cancer surgical treatment
1 Impact of magnetic resonance on breast cancer
surgical treatment
- D. Martínez-Cecilia, M. Álvarez Benito, P. Rioja
Torres, A Arjona Sánchez, C. Muñoz Villanueva,
G. Bascuñana Estudillo, S. Rufián Peña.
Breast Multidisciplinary Unit. Hospital
Universitario Reina Sofía. Córdoba.
2(No Transcript)
3MRI in breast cancer
- Equivocal mammogram or ultrasound.
- Axillary node malignancy and unknown site of
primary tumor. - Monitoring response to chemotherapy .
- Screening in high-risk populations.
- Nipple discharge.
- Breast cancer staging
4Staging. What are we doing?
- Breast conserving surgery 8,8-14 recurrency
- 11-57 multifocal multicentric
- MX and US lack of sensitivity MRI 100
- MRI Occult sinchronic cancer 16-37
- MRI Treatment changes 11-18
- MRI Contralateral cancer from 3-6 to 3-19
Fisher B, Anderson S, Bryant J, et al. Twenty
year follow-up a randomized trial comparing
mastectomy, lumpectomy, and lumpectomy plus
irradiation for the treatment of invasive breast
cancer. N Engl J Med. 20023471233-1241.
5Staging Pitfalls
- MRI specificity 65-79!
- Histologic confirmation of multifocal disease
before surgery! - Is detection of occult synchronous cancers,
including noninvasive ones, clinical significant? - Does it improve the survival of our patients?
6Aims
- Accuracy of MRI for estimating tumor size vs
conventional methods. - Evaluate MRI ability for detecting
- Multifocality, multicentricity, bilaterality.
- Evaluate the impact in the surgical management of
newly diagnosed breast cancers.
7Patients and methods
- Retrospective review.
- January 2005-2007 712 breast cancer pac.
- 331 MRI 1.5 tesla, gadolinium.
- New suspicious foci Mx, US, Core biopsy.
- Exclusion criteria
- Preoperative chemotherapy, recurrent cancer, lack
of MRI or pathology
8Results Tumor size
N 249
Non parametric correlation Spearman's rank
coefficient
Sig 0,01 (bilateral).
9Results aditional foci
20 aditional foci
N 249
18 patients 8
10Histology
11Results changes in surgical treatment
32 patients 13
12was it worthy?
11 conversion rate to mastectomy 7 beneficial
mastec. 2.4 unnecessary
13Controversies
Benefit from wider excisions in BCS
Unnecessary biopsies
78 False-positive rate
3
Biliamora K, Cambic A, Hansen N, Bethke K.
Evaluating the impact of preoperative breast
magnetic resonance imaging On the surgical
management of newly diagnosed breast cancers.
Arch Surg. 2007142441-447.
14Conclusions
- MRI was the best technique in assesing tumor size
in preoperative staging of breast cancer. - MRI diagnosed additional disease foci in 8 of
the patients, contralateral in 1,2. - Mastectomy conversion rate was 11, beneficial
mastectomies in 7.
15Conclusions
- MRI changed surgical management in 13 of the
patients, improving it in, at least, 9. - MRI has been incorporated to our staging protocol
in breast cancer. - MRI should be considered in preoperative staging
in every patient with newly diagnosed breast
cancer.
16